TrimRX
US$ 20.91
glp 1 addiction Not just obesity: GLP-1 receptor agonists advance on Five things to know about
Description
Pfizer is developing danuglipron (PF-06882961) - an oral small-molecule GLP-1 receptor agonist
Usually drugs that go into shortage are cheap generics, not expensive brand-name ones that are still under patent, Tenille Davis, PharmD, chief advocacy officer at the Alliance for Pharmacy Compounding, tells SELF
However, a fear has recently emerged that oral GLP-1 analogs will cannibalize the market share of injectables
For instance, a patient may require a liquid version of a medication that is only available in tablet form
Population-based cohort study
